Clarivate (Clarivate) Interest Expense : $-294 Mil (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Clarivate Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Clarivate's interest expense for the three months ended in Dec. 2023 was $ -75 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-294 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Clarivate's Operating Income for the three months ended in Dec. 2023 was $ 95 Mil. Clarivate's Interest Expense for the three months ended in Dec. 2023 was $ -75 Mil. Clarivate's Interest Coverage for the quarter that ended in Dec. 2023 was 1.26. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Clarivate Interest Expense Historical Data

The historical data trend for Clarivate's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clarivate Interest Expense Chart

Clarivate Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-157.69

-111.90

-252.50

-270.30

-293.70

Clarivate Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-77.00	-73.60	-73.00	-71.90	-75.20

Clarivate Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-294 Mil.

Clarivate (NYSE:CLVT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Clarivate's Interest Expense for the three months ended in Dec. 2023 was $-75 Mil. Its Operating Income for the three months ended in Dec. 2023 was $95 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was $4,784 Mil.

Clarivate's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	94.8	/	-75.2
	=	1.26

The higher the ratio, the stronger the company's financial strength is.

Clarivate (Clarivate) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Software » Clarivate PLC (NYSE:CLVT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

16A:Germany

Address

70 St. Mary Axe, London, GBR, EC3A 8BE

Website

https://www.clarivate.com

Clarivate PLC is an information, analytics, and workflow solutions company. It operates in three segments: Academia and Government; Life Sciences and Healthcare and Intellectual Property. The company generates maximum revenue from the Academia and Government segment. The A&G segment consists of Academia and Government product group, which drives research excellence across institutions, empower researchers to tackle today's global challenges and help academic institutions and libraries improve operational efficiency and effectiveness. Geographically, it derives a majority of its revenue from the Americas.

Executives

Melanie Margolin	officer: Chief Legal Officer	1000 SAGAMORE PARKWAY SOUTH, LAFAYETTE IN 47905
Saurabh Saha	director	C/O CENTESSA PHARMACEUTICALS PLC, 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESHIRE X0 WA14 2DT
Henry Levy	officer: President, LS&H	70 ST. MARY AXE, LONDON X0 EC3 8BA
Bar Veinstein	officer: President, A&G	70 ST. MARY AXE, LONDON X0 EC3 8BA
James Gordon Samson	officer: President, IP Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE 1 8EZ
Andrew Miles Snyder	director	111 WEST 57TH STREET, 9TH FLOOR, NEW YORK NY 10019
Wendell E. Pritchett	director	TOLL BROTHERS, INC., 1140 VIRGINIA DRIVE, FORT WASHINGTON PA 19034
Jonathan Gear	director, officer: Chief Executive Officer-Elect	C/O IHS MARKIT LTD., 4TH FLOOR, ROPEMAKE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Michael M Easton	officer: Senior VP, Finance/CAO	4TH FLOOR ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Stefano Maestri	officer: Chief Technology Officer	70 ST MARY AXE, LONDON X0 EC3 8BA
Jonathan Mark Collins	officer: Executive Vice President/CFO	50196 VENICE COURT, NORTHVILLE MI 48168
Mukhtar Ahmed	officer: President, Science Group	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SEL 8EZ
Michael J Angelakis	director	40 MORRIS AVENUE, BRYN MAWR PA 19010
Heather Matzke-hamlin	officer: Acting Chief Acctg Officer	4TH FLOOR, ROPEMAKER PLACE, 25 ROPEMAKER STREET, LONDON X0 EC2Y 9LY
Steen Lomholt-thomsen	officer: Chief Revenue Officer	FRIARS HOUSE, 160 BLACKFRIARS ROAD, LONDON X0 SE1 8EZ